Objective Obstructive sleep apnea syndrome (OSAS) 
Introduction

Obstructive sleep apnea syndrome (OSAS) is a common disorder which is characterized by repetitive cessation of breathing during sleep and daytime consequences which include subjective daytime sleepiness, impaired cognitive function, and impaired memory (1). The prevalence of OSAS is high (2-4% of the adult population) (2); a recent review estimates that OSAS affects approximately 5% of adults (3). This problem is also common in Asians (4). OSAS has been reported to be associated with high rates of morbidity and mortality due to cardiovascular diseases (5). Previous reports have shown a linked relationship between OSAS and obesity (6). Obesity may play a role in the development of diabetes mellitus, hypertension, and hyperlipidemia (7). Thus, patients with OSAS may be burdened with multiple risk factors related to obesity for cardiovascular diseases. Metabolic syndrome, a constellation of cardiovascular risk factors that includes obesity, hypertension, insulin resistance, and dyslipidemia, has been reported to be common in patients with OSAS (8). Insulin resistance, a key component of cardiovascular diseases, is an association linked with obesity; however the results of published data on the relationship between OSAS and glucose intolerance are conflicting (9-12). It is still controversial whether or not OSAS independently plays a role in the development of glucose intolerance or diabetes mellitus. In this study we performed a cross-sectional study in Japanese patients with OSAS to clarify the prevalence of glucose intolerance in OSAS patients and to determine what measurement is a predictor of insulin resistance in OSAS patients.
Methods
Subject
Statistical analysis
Statistical analysis was performed using StatView software version 5.0 (SAS Institute, Cary, NC). Continuous variables were expressed as the mean ± standard deviation (SD). Comparisons of continuous clinical variables between controls and OSAS groups with different categorization by
Results
Characteristics of OSAS patients and controls
Prevalence of glucose intolerance and diabetes mellitus
The prevalence of type 2 DM or IGT in each OSAS group and control group is presented in Fig. 1 
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OSAS and glucose intolerance using
